{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:45:50Z","timestamp":1770893150616,"version":"3.50.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1210\/js.2018-00159","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T03:59:01Z","timestamp":1532145541000},"page":"870-881","source":"Crossref","is-referenced-by-count":9,"title":["Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children"],"prefix":"10.1210","volume":"2","author":[{"given":"Satu","family":"Sepp\u00e4","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland"},{"name":"Department of Pediatrics, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Tenhola","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland"},{"name":"Department of Pediatrics, University of Eastern Finland, Kuopio, Finland"},{"name":"Department of Pediatrics, Kymenlaakso Central Hospital, Kotka, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimo","family":"Voutilainen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland"},{"name":"Department of Pediatrics, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"issue":"1","key":"2019041123594432300_B1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.metabol.2014.10.016","article-title":"From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century","volume":"64","author":"Bl\u00fcher","year":"2015","journal-title":"Metabolism"},{"issue":"5","key":"2019041123594432300_B2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"2019041123594432300_B3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cyto.2015.05.005","article-title":"IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance","volume":"75","author":"Ballak","year":"2015","journal-title":"Cytokine"},{"issue":"10","key":"2019041123594432300_B4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tem.2015.08.001","article-title":"The IL-1 pathway in type 2 diabetes and cardiovascular complications","volume":"26","author":"Herder","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2019041123594432300_B5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"issue":"14","key":"2019041123594432300_B6","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019041123594432300_B7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.52.5.1104","article-title":"Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation","volume":"52","author":"Juge-Aubry","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"2019041123594432300_B8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/ATVBAHA.117.309307","article-title":"Circulating levels of interleukin 1-receptor antagonist and risk of cardiovascular disease: meta-analysis of six population-based cohorts","volume":"37","author":"Herder","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2019041123594432300_B9","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/dc06-0147","article-title":"Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects","volume":"29","author":"Ruotsalainen","year":"2006","journal-title":"Diabetes Care"},{"issue":"7","key":"2019041123594432300_B10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc14-3008","article-title":"Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes","volume":"38","author":"Grossmann","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"2019041123594432300_B11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2362.2001.00743.x","article-title":"Pro-inflammatory cytokines in patients with essential hypertension","volume":"31","author":"Peeters","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"2019041123594432300_B12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/oby.2012.85","article-title":"Inflammatory and prothrombotic states in obese children of European descent","volume":"20","author":"Stoppa-Vaucher","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"8663","key":"2019041123594432300_B13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","article-title":"Weight in infancy and death from ischaemic heart disease","volume":"2","author":"Barker","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"2019041123594432300_B14","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1542\/peds.2011-3093","article-title":"Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review","volume":"129","author":"Davis","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"2019041123594432300_B15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1095\/biolreprod.115.135780","article-title":"Preeclampsia as modulator of offspring health","volume":"94","author":"Stojanovska","year":"2016","journal-title":"Biol Reprod"},{"issue":"4","key":"2019041123594432300_B16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0002-9378(88)90090-7","article-title":"The classification and definition of the hypertensive disorders of pregnancy","volume":"158","author":"Davey","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"2019041123594432300_B17","first-page":"1540","article-title":"[Characteristic of recent fetal growth curves in Finland]","volume":"105","author":"Pihkala","year":"1989","journal-title":"Duodecim"},{"issue":"5","key":"2019041123594432300_B18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1203\/00006450-200011000-00012","article-title":"Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age","volume":"48","author":"Tenhola","year":"2000","journal-title":"Pediatr Res"},{"issue":"4","key":"2019041123594432300_B19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.HYP.0000013864.24138.A5","article-title":"Ambulatory blood pressure in 12-year-old children born small for gestational age","volume":"39","author":"Rahiala","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"2019041123594432300_B20","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2002-020903","article-title":"Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia","volume":"88","author":"Tenhola","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123594432300_B21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1203\/01.pdr.0000196734.54473.e3","article-title":"Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring","volume":"59","author":"Tenhola","year":"2006","journal-title":"Pediatr Res"},{"issue":"3","key":"2019041123594432300_B22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853890.2010.515603","article-title":"New Finnish growth references for children and adolescents aged 0 to 20 years: length\/height-for-age, weight-for-length\/height, and body mass index-for-age","volume":"43","author":"Saari","year":"2011","journal-title":"Ann Med"},{"issue":"1","key":"2019041123594432300_B23","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2019041123594432300_B24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family--balance between agonists and antagonists in inflammatory diseases","volume":"76","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"2019041123594432300_B25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/db15-0881","article-title":"Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts","volume":"65","author":"Nowak","year":"2016","journal-title":"Diabetes"},{"issue":"12","key":"2019041123594432300_B26","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.2337\/diabetes.51.12.3582","article-title":"Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes","volume":"51","author":"Marculescu","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"2019041123594432300_B27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/07853890903022801","article-title":"Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity","volume":"41","author":"Cartier","year":"2009","journal-title":"Ann Med"},{"issue":"11","key":"2019041123594432300_B28","first-page":"3227","article-title":"Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo","volume":"80","author":"Yki-J\u00e4rvinen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041123594432300_B29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/dc08-1618","article-title":"Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty","volume":"32","author":"S\u00f8rensen","year":"2009","journal-title":"Diabetes Care"},{"issue":"5-6","key":"2019041123594432300_B30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000345546","article-title":"Inflammatory markers and clustered cardiovascular disease risk factors in Danish adolescents","volume":"78","author":"Bugge","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2019041123594432300_B31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1210\/js.2017-00437","article-title":"Plasma IL-1 receptor antagonist concentration has an inverse association with birth weight in prepubertal children","volume":"2","author":"Nordman","year":"2018","journal-title":"J Endocr Soc"},{"issue":"3","key":"2019041123594432300_B32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.numecd.2010.07.001","article-title":"The association of adiponectin and low-grade inflammation with the course of metabolic syndrome","volume":"22","author":"Ahonen","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2019041123594432300_B33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(99)00312-3","article-title":"C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors","volume":"149","author":"Cook","year":"2000","journal-title":"Atherosclerosis"},{"issue":"23","key":"2019041123594432300_B34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"2019041123594432300_B35","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2013-3902","article-title":"Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty (Earlybird 58)","volume":"99","author":"Pinkney","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123594432300_B36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2014.01.003","article-title":"Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2) and lipoprotein(a) (Lp(a))","volume":"28","author":"Dallmeier","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"2019041123594432300_B37","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/nutd.2015.30","article-title":"Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans","volume":"5","author":"Bissonnette","year":"2015","journal-title":"Nutr Diabetes"},{"issue":"19","key":"2019041123594432300_B38","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.0000097113.11419.9E","article-title":"Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"108","author":"Williams","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"2019041123594432300_B39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/diacare.25.3.579","article-title":"Hypertriglyceridemic hyperapoB in type 2 diabetes","volume":"25","author":"Sniderman","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"2019041123594432300_B40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2249.2004.02531.x","article-title":"Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals","volume":"137","author":"Cullup","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2019041123594432300_B41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.metabol.2009.08.019","article-title":"Cytokines and clustered cardiovascular risk factors in children","volume":"59","author":"Andersen","year":"2010","journal-title":"Metabolism"},{"issue":"12","key":"2019041123594432300_B42","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1210\/jc.2010-1047","article-title":"Insulin resistance in children: consensus, perspective, and future directions","volume":"95","author":"Levy-Marchal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041123594432300_B43","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/2\/8\/870\/25428100\/js.2018-00159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:54:39Z","timestamp":1661648079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/2\/8\/870\/5048346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,4]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2018-00159","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,7,4]]}}}